Tag Archives: (TSLA)

Shaken, Not Stirred

Did you know the antibody behind Johnson & Johnson’s (JNJ) blockbuster cancer drug Darzalex was actually developed by a small Danish biotech most investors have never heard of? That biotech is Genmab (GMAB), and they’re like the secret agent of the biotech world — operating in the shadows while their technology powers some of the […]

May 14 Biweekly Strategy Webinar Q&A

Below, please find subscribers’ Q&A for the May 14 Mad Hedge Fund Trader Global Strategy Webinar, broadcast from Incline Village, NV. Q: What are the chances of Tesla (TSLA) getting their robotaxis up this year? A: No chance. Elon Musk is someone who overpromises and underdelivers on timetables. He uses that as a whip to […]

The Market Outlook for the Week Ahead, or Waiting for the Missiles to Hit

When I was in Ukraine, the air raid sirens used to go off every night exactly at 2:00 AM. The Russian goal was to deprive the civilian population of sleep and to make their lives miserable. It was also when the country was least able to defend itself. You knew the missiles were on the […]

AI And Lower Employee Wages

Students hoping to become bankers shouldn’t study finance, they should dive into programming. This is the big takeaway from how investment banks are run these days. Gone are the moments when finance degrees were the hottest commodity; now it is all about generative AI. Artificial intelligence (AI) could replace the equivalent of 300 million full-time […]

The Market Outlook for the Week Ahead, or Expensive Again

We certainly are having to work hard for our crust of bread in the stock market this year. April brought us the fastest downturn in stocks in 16 years, immediately followed by the sharpest upturn in 21 years. It’s like running for a treadmill heart test, but a sadistic doctor keeps raising the angle of […]